Insulet Corporation splits its revenue into 3 lines in its filings. The largest line in Q3 of fiscal 2026, the quarter ended Sep 30, 2026 was U.S.Omnipod at $570.4 million, 68% of the total.
USD in millions. The percent under a figure is the change from the same quarter a year earlier.
| Line |
TTM
Sep 30, 2026
|
Q3 FY2026
Sep 30, 2026
|
Q2 FY2026
Jun 30, 2026
|
Q1 FY2026
Mar 31, 2026
|
Q4 FY2025
Dec 31, 2025
|
Q3 FY2025
Sep 30, 2025
|
Q2 FY2025
Jun 30, 2025
|
Q1 FY2025
Mar 31, 2025
|
Q4 FY2024
Dec 31, 2024
|
|---|---|---|---|---|---|---|---|---|---|
| Revenue |
3,189
|
842
|
802
|
762
|
784
|
706
|
649
|
569
|
598
|
| U.S.Omnipod |
2,198
+22.4%
share 68.9%
|
570
+14.7%
share 67.7%
|
544
+20.1%
share 67.9%
|
516
+28.4%
share 67.7%
|
568
+28.0%
share 72.4%
|
497
share 70.4%
|
453
share 69.8%
|
402
share 70.6%
|
444
share 74.3%
|
| International Omnipod |
975
+42.9%
share 30.6%
|
266
+31.7%
share 31.6%
|
252
+35.5%
share 31.4%
|
243
+59.5%
share 31.9%
|
214
+50.8%
share 27.3%
|
202
share 28.6%
|
186
share 28.6%
|
152
share 26.8%
|
142
share 23.8%
|
| Drug Delivery |
16
-62.5%
share 0.5%
|
6
-22.5%
share 0.7%
|
6
-43.1%
share 0.7%
|
3
-77.9%
share 0.4%
|
2
-83.9%
share 0.2%
|
7
share 1.0%
|
10
share 1.6%
|
15
share 2.6%
|
12
share 2.0%
|
How these figures are calculated
Quarterly columns are single-quarter amounts. When a 10-Q reports only a year-to-date total, as cash flow statements do, the quarter is that total minus the previous quarter's year-to-date total. The fourth quarter is the annual report's full year minus the first nine months. A column marked YTD is a year-to-date total, shown when the earlier report needed for the single quarter is missing. USD in millions. Each group is a separate split of total revenue, so the groups are not added together. Share of revenue is that line divided by total revenue. The first column adds the latest year-to-date segment amount to the last fiscal year and subtracts the year-ago year-to-date amount. More on our methodology.
Company profile
- Industry
- Surgical & Medical Instruments & Apparatus (SIC 3841)
- Listed as
- PODD (Nasdaq)
- Fiscal year ends
- December 31
- Incorporated in
- DE
- Headquarters
- Acton, MA
- SEC filer status
- Large accelerated filer
- SEC CIK
- 1145197
Other Surgical & Medical Instruments & Apparatus companies
- Stryker Corp SYK
- 3M Co MMM
- Boston Scientific Corp BSX
- Becton Dickinson & Co BDX
- Medline Inc. MDLN
- Resmed Inc RMD
- Dexcom Inc DXCM
- Fresenius SE & Co. KGaA FSNUY
All 151 Surgical & Medical Instruments & Apparatus companies
Source: SEC EDGAR filings. This is company-reported data, not investment advice.